Anika Therapeutics Inc (ANIK)
25.58
-0.32
(-1.24%)
USD |
NASDAQ |
Apr 25, 16:00
25.61
+0.03
(+0.12%)
After-Hours: 20:00
Anika Therapeutics Free Cash Flow (Quarterly): 1.798M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.798M |
September 30, 2023 | 5.744M |
June 30, 2023 | -9.75M |
March 31, 2023 | -5.007M |
December 31, 2022 | -2.048M |
September 30, 2022 | 1.018M |
June 30, 2022 | 1.148M |
March 31, 2022 | -3.195M |
December 31, 2021 | 3.345M |
September 30, 2021 | 0.778M |
June 30, 2021 | 1.979M |
March 31, 2021 | -2.848M |
December 31, 2020 | 2.138M |
September 30, 2020 | 5.594M |
June 30, 2020 | 3.383M |
March 31, 2020 | 0.322M |
December 31, 2019 | 12.75M |
September 30, 2019 | 9.623M |
June 30, 2019 | 4.369M |
March 31, 2019 | 7.432M |
December 31, 2018 | 9.85M |
September 30, 2018 | 9.632M |
June 30, 2018 | 3.731M |
March 31, 2018 | 7.049M |
December 31, 2017 | 4.507M |
Date | Value |
---|---|
September 30, 2017 | 9.511M |
June 30, 2017 | 4.029M |
March 31, 2017 | 13.78M |
December 31, 2016 | 4.664M |
September 30, 2016 | 8.577M |
June 30, 2016 | -4.433M |
March 31, 2016 | 1.626M |
December 31, 2015 | 8.924M |
September 30, 2015 | 8.012M |
June 30, 2015 | 10.02M |
March 31, 2015 | 3.728M |
December 31, 2014 | 14.12M |
September 30, 2014 | 7.143M |
June 30, 2014 | 3.839M |
March 31, 2014 | 13.32M |
December 31, 2013 | 7.801M |
September 30, 2013 | 7.400M |
June 30, 2013 | 3.49M |
March 31, 2013 | 6.033M |
December 31, 2012 | 4.600M |
September 30, 2012 | 2.054M |
June 30, 2012 | 4.303M |
March 31, 2012 | -1.914M |
December 31, 2011 | 6.861M |
September 30, 2011 | 2.678M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.75M
Minimum
Jun 2023
12.75M
Maximum
Dec 2019
1.639M
Average
1.798M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
The Cooper Companies Inc | 4.60M |
Staar Surgical Co | 28.88M |
OrthoPediatrics Corp | -13.48M |
NexGel Inc | -0.672M |
Innovative Eyewear Inc | -1.128M |